Papillomavirus Infection, Transsexualism
Conditions
Brief summary
In this study, Human Papilloma Virus (HPV) prevalence will be determined once in the urine of 200 trans people. In addition, subjects will be asked to complete a questionnaire about their sexual orientation, which is adapted from the largest published study.
Detailed description
All transpeople who visit the outpatient clinic are asked to participate in the study. After being informed and signing the Informed Consent Form, the subjects are asked to give first-void urine and fill out the survey. The urine samples are sent pseudonymously to the University of Ljubljana for analysis. The subjects will be informed about their results within 3 weeks.If the result is positive, the subjects will be offered voluntary further care in our HPV outpatient clinic. However, this will take place outside the study. The data collected there can be used for further analyses.
Interventions
DIAGNOSTIC_TESTColli-Pee urine collection device
first-void urine is collected using Colli-Pee and subsequently analyzed using Anyplex™ II HPV HR Detection from Seegene.
OTHERSurvey
Subjects are asked to complete a survey that includes questions about sexual orientation, hormone therapy, gender reassignment surgery, number of sexual partners, HPV vaccination, and smoking
Sponsors
Sophie Pils
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Transpeople * Age over 18 years * Sufficient knowledge of German
Exclusion criteria
* Age under 18 years * Insufficient knowledge of German
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| HPV prevalence in transpeople | one year | HPV prevalence in transpeople |
Countries
Austria, Slovenia
Outcome results
None listed